Skip to main content
Year archive

Mendus — 2018 filings

All 56 regulatory filings released by Mendus (IMMU) in 2018, sourced directly from the official regulator.

56 Filings
2018 Period
2018 filings (56)
Filing Released Lang
Major Shareholding Notification 2018
Major Shareholding Notification
2018-12-28 English
Förändring av antal aktier och röster i Immunicum AB (publ) efter genomförd riktad emission
Declaration of Voting Results & Voting Rights Announcements
2018-12-28 Swedish
Major Shareholding Notification 2018
Major Shareholding Notification
2018-12-18 English
Immunicum offentliggör utfallet i nyemissionerna - bolaget tillförs 351 MSEK
Share Issue/Capital Change
2018-12-13 Swedish
Immunicum AB (publ) Publishes the Outcome in the Share Issues and Raises SEK 351M
Share Issue/Capital Change
2018-12-13 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-12-12 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-12-06 English
Immunicum offentliggör prospekt i samband med företrädesemission och riktad emission
Capital/Financing Update
2018-11-23 Swedish
Immunicum AB (publ) Publishes Prospectus in Connection with Rights Issue and Directed Issue
Capital/Financing Update
2018-11-23 English
Immunicum tillkännager samarbete med Merck KGaA, Darmstadt, Tyskland och Pfizer för utvärdering av ilixadencel i kombination med avelumab i den planerade fas Ib/II multi-indikationsstudien ILIAD
Regulatory Filings
2018-11-16 Swedish
Immunicum AB (publ) Announces Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to Evaluate Ilixadencel in Combination with Avelumab in Multi-Indication Phase Ib/II Study
Regulatory Filings
2018-11-16 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-11-12 English
Kommuniké från extra bolagsstämman i Immunicum AB (publ) den 8 november 2018
Share Issue/Capital Change
2018-11-08 Swedish
Report from Extraordinary General Meeting of Immunicum AB (publ) on 8 November 2018
AGM Information
2018-11-08 English
Interim / Quarterly Report 2018
Interim / Quarterly Report Q3 2018
2018-11-07 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report 9M 2018
2018-11-07 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-11-05 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-10-30 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-10-26 English
Valberedning utsedd inför Immunicum ABs årsstämma 2019
Governance Information
2018-10-19 Swedish
Immunicum AB (publ) Announces Nomination Committee for AGM 2019
Board/Management Information
2018-10-19 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-10-18 English
Immunicum AB (publ) förtydligar information kring riktad emission
Capital/Financing Update
2018-10-16 Swedish
Immunicum AB (publ) Clarifies Information Regarding Directed Issue
Capital/Financing Update
2018-10-16 English
Immunicum AB (publ) lämnar information med anledning av handelsstopp och pågående förhandling avseende potentiellt samarbete
Regulatory Filings
2018-10-01 Swedish
Immunicum AB (publ) Gives Information on Trading Halt and Ongoing Negotiations for a Potential Collaboration
Regulatory Filings
2018-10-01 English
Interim / Quarterly Report 2018
Interim / Quarterly Report Q2 2018
2018-08-17 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report H1 2018
2018-08-17 English
Immunicum AB (publ) meddelar att FDA godkänt protokollet som möjliggör starten av en utökad Fas Ib/II-multi-indikationsstudie med kombinationsbehandling
Regulatory Filings
2018-07-23 Swedish
Immunicum AB (publ) Announces Protocol Approval by the FDA Enabling the Initiation of Expanded Multi-indication Phase Ib/II Combination Trial
Regulatory Filings
2018-07-23 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-07-11 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-07-10 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-05-30 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-05-22 English
Immunicum AB (publ) Announces End of Enrollment in Phase I/II GIST Clinical Trial
Regulatory Filings
2018-05-21 English
Immunicum AB (publ) meddelar att rekryteringen till den kliniska fas I/II-studien GIST är slutförd
Regulatory Filings
2018-05-21 Swedish
Major Shareholding Notification 2018
Major Shareholding Notification
2018-05-16 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-05-15 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-05-11 English
Interim / Quarterly Report 2018
Interim / Quarterly Report Q1 2018
2018-05-04 Swedish
Earnings Release 2018
Earnings Release Q1 2018
2018-05-04 English
Kommuniké från årsstämma i Immunicum AB (publ) den 25 april 2018
AGM Information
2018-04-25 Swedish
Report from the Annual General Meeting of Immunicum AB (publ) on April 25, 2018
AGM Information
2018-04-25 English
Audit Report / Information 2017
Audit Report / Information FY 2017
2018-04-03 Swedish
Annual Report 2017
Annual Report FY 2017
2018-04-03 English
Kallelse till årsstämma i Immunicum AB (publ)
AGM Information
2018-03-26 Swedish
Notice of Annual General Meeting in Immunicum AB (publ)
AGM Information
2018-03-26 English
Immunicum AB: The Nomination Committee of Immunicum AB (publ) proposes Michael Oredsson as new Chairman of the Board
Board/Management Information
2018-03-14 English
Immunicum AB: Valberedningen föreslår Michael Oredsson som ny styrelseordförande i Immunicum AB (publ)
Board/Management Information
2018-03-14 Swedish
Major Shareholding Notification 2018
Major Shareholding Notification
2018-03-01 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-02-27 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-02-16 English
Earnings Release 2017
Earnings Release Q4 2017
2018-02-16 Swedish
Earnings Release 2017
Earnings Release Q4 2017
2018-02-16 English
Immunicum rekryterar Michaela Gertz som ny CFO
Board/Management Information
2018-01-31 Swedish
Michaela Gertz Joins Immunicum as CFO
Board/Management Information
2018-01-31 English